We are live on ! Find out more
ABCL icon

AbCellera Biologics

190 hedge funds and large institutions have $1.17B invested in AbCellera Biologics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more call options, than puts

Call options by funds: $49.9M | Put options by funds: $11.1M

193% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 15

103% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 37

18% more funds holding

Funds holding: 161190 (+29)

1.21% more ownership

Funds ownership: 41.52%42.73% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

4% less capital invested

Capital invested by funds: $1.22B → $1.17B (-$49.6M)

Holders
190
Holders Change
+29
Holders Change %
+18.01%
% of All Funds
3.27%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
44
Increased
75
Reduced
37
Closed
15
Calls
$49.9M
Puts
$11.1M
Net Calls
+$38.9M
Net Calls Change
+$22.4M
Name Holding Trade Value Shares
Change
Change in
Stake
GWM
201
Geneos Wealth Management
Colorado
-$107K -10,087 Closed
WAM
202
Worth Asset Management
Texas
-$40K -3,750 Closed
Rockefeller Capital Management
203
Rockefeller Capital Management
New York
-$5K -500 Closed
SWM
204
Spire Wealth Management
Virginia
-$1K -55 Closed
C
205
Covestor
United Kingdom
+$197 +18 New